| __timestamp | Bristol-Myers Squibb Company | Ligand Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 11947000000 | 55402000 |
| Thursday, January 1, 2015 | 12651000000 | 66107000 |
| Friday, January 1, 2016 | 14481000000 | 103402000 |
| Sunday, January 1, 2017 | 14710000000 | 135736000 |
| Monday, January 1, 2018 | 16014000000 | 245116000 |
| Tuesday, January 1, 2019 | 18067000000 | 108935000 |
| Wednesday, January 1, 2020 | 30745000000 | 156000000 |
| Friday, January 1, 2021 | 36445000000 | 214957000 |
| Saturday, January 1, 2022 | 36022000000 | 143418000 |
| Sunday, January 1, 2023 | 34313000000 | 96265000 |
| Monday, January 1, 2024 | 36351000000 |
Igniting the spark of knowledge
In the ever-evolving pharmaceutical industry, the financial health of companies is a key indicator of their market position and potential for innovation. Over the past decade, Bristol-Myers Squibb Company has demonstrated a robust growth trajectory in gross profit, with a remarkable 187% increase from 2014 to 2023. This growth is highlighted by a significant leap in 2020, where profits surged by over 70% compared to the previous year, reflecting strategic acquisitions and successful product launches.
Conversely, Ligand Pharmaceuticals Incorporated, while smaller in scale, has shown a steady upward trend, peaking in 2018 with a 342% increase from its 2014 figures. Despite a slight decline in recent years, Ligand's innovative approach in drug discovery and licensing continues to position it as a formidable player in niche markets. This comparison underscores the diverse strategies and market dynamics shaping the pharmaceutical landscape today.
AstraZeneca PLC and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Who Generates Higher Gross Profit? Novartis AG or Bristol-Myers Squibb Company
Gross Profit Comparison: Amgen Inc. and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Trends Compared: Bristol-Myers Squibb Company vs Viatris Inc.
Bristol-Myers Squibb Company and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Bristol-Myers Squibb Company and Ligand Pharmaceuticals Incorporated: A Comprehensive Revenue Analysis
Key Insights on Gross Profit: Bristol-Myers Squibb Company vs HUTCHMED (China) Limited
Walgreens Boots Alliance, Inc. vs Ligand Pharmaceuticals Incorporated: A Gross Profit Performance Breakdown
Gross Profit Comparison: Pharming Group N.V. and Ligand Pharmaceuticals Incorporated Trends
Gross Profit Trends Compared: Vericel Corporation vs Ligand Pharmaceuticals Incorporated
Gross Profit Comparison: Arrowhead Pharmaceuticals, Inc. and Ligand Pharmaceuticals Incorporated Trends
Key Insights on Gross Profit: Ligand Pharmaceuticals Incorporated vs MiMedx Group, Inc.